Exact Mass: 306.0327
Exact Mass Matches: 306.0327
Found 92 metabolites which its exact mass value is equals to given mass value 306.0327,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Uridine 2',3'-cyclic phosphate
Uridine 2,3-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3 end of mRNAs and other small RNAs. Uridine 2,3-cyclic phosphate is a substrate for the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1. [HMDB] Uridine 2,3-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3 end of mRNAs and other small RNAs. Uridine 2,3-cyclic phosphate is a substrate for the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1.
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate
2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate is part of the Flavonoid metabolism pathway. It is a substrate for: Pirin.
Vadadustat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid 4'-sulfate
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid sulfate
uracil 5-beta-D-ribofuranosyl-2,3-cyclic monophosphate
Methyl brevifolincarboxylate
Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a radical scavenger and a platelet aggregation inhibitor. It is an organic heterotricyclic compound, a delta-lactone, a member of phenols and a cyclic ketone. Methyl brevifolincarboxylate is a natural product found in Euphorbia maculata and Phyllanthus niruri with data available. An organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity.
4-Chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one
4-Chloro-1,6-dihydroxy-3-methoxy-8-methyl-9H-xanthen-9-one
9H-Xanthen-9-one, 2-chloro-1,8-dihydroxy-5-methoxy-6-methyl-
2-Chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one
3,5-cUMP|3,5-cyclic UMP|CUMP|cyclic uridine 3,5-monophosphate|Cyclic-3,5-UMP|O3,O5-hydroxyphosphoryl-uridine|uridine 3,5-cyclic monophosphate
luteolinidin
Luteolinidin chloride is an anthocyanidin chloride that has luteolinidin as the cationic counterpart. It contains a luteolinidin. Luteolinidin is a natural deoxyanthocyanidin, isolated from Sorghum bicolor [1]. Luteolinidin is a potent CD38 inhibitor which can protect the heart against I/R injury with preservation of eNOS function and prevention of endothelial dysfunction in vivo[2]. Luteolinidin is a natural deoxyanthocyanidin, isolated from Sorghum bicolor [1]. Luteolinidin is a potent CD38 inhibitor which can protect the heart against I/R injury with preservation of eNOS function and prevention of endothelial dysfunction in vivo[2].
Pelargonidin
Pelargonidin chloride is an anthocyanidin chloride that has pelargonidin as the cationic counterpart. It has a role as a phytoestrogen and a plant metabolite. It contains a pelargonidin. An anthocyanidin chloride that has pelargonidin as the cationic counterpart. Pelargonidin chloride is a scavenger of nitric oxide radical and has antioxidant activities[1]. Pelargonidin chloride is a scavenger of nitric oxide radical and has antioxidant activities[1].
6-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)NAPHTHALEN-2-OL
Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
4-amino-2-[(2-chlorophenoxy)methyl]-6-methylsulfanylpyrimidine-5-carbonitrile
2-[[3,5-bis(trifluoromethyl)phenyl]hydrazinylidene]propanedinitrile
2-(2,4-DIFLUORO-PHENYL)-5-THIOPHEN-2-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID
6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine
Deoxyuridine-phosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate
N-(6-chloro-1,3-benzothiazol-2-yl)-1,5-dimethyl-3-pyrazolecarboxamide
2-[5-[2-[(4-Methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid
2-chloro-7,9-dihydroxy-3-methoxy-1-methyl-6H-benzo[c]chromen-6-one
(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine
2,3-cyclic ump
A 2,3-cyclic pyrimidine nucleotide in which uridine is the parent nucleoside.
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid
dUMP(2-)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-deoxyuridine 5-monophosphate (dUMP); major species at pH 7.3.
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
A differentiation-inducing factor that is hexaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate
palmariol B
A benzochromenone that is 6H-benzo[c]chromen-6-one which is substituted by a methyl group at position 1, chloro group at position 2, hydroxy groups at positions positions 3 and 7, and by a methoxy group at position 9.
hyalodendriol C
An organic heterotricyclic compound that is 6H-benzo[c]chromen-6-one substituted by a methyl group at position 1, chloro group at position 2, methoxy group at position 3, and by hydroxy groups at positions 7 and 9. It is a metabolite isolated from Hyalodendriella species.
